| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 10,400 | 10,513 | 10,736 | 12,145 | | Cost of Revenue | 5,278 | 5,684 | 5,688 | 7,592 | | | Gross Profit | 5,122 | 4,829 | 5,048 | 4,553 | | | Operating Expenses | | Research Development | 888 | 906 | 841 | 1,014 | | Selling General and Administrative | 3,265 | 3,524 | 3,844 | 4,486 | | Non Recurring |
-
|
-
|
-
| 5,364 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 969 | 399 | 363 | (6,311) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 800 |
-
|
-
| | Earnings Before Interest And Taxes | 772 | 1,199 | 363 | (6,311) | | Interest Expense | (133) | (6) | 139 | 81 | | Income Before Tax | 905 | 1,205 | 224 | (6,392) | | Income Tax Expense | 259 | 7 |
-
| 111 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 646 | 1,198 | 224 | (6,503) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 646 | 1,198 | 224 | (6,503) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $646 | $1,198 | $224 | ($6,503) |
|
0.51% Nasdaq 
Income Statement
